Insider · CIK 0001356256

Myers Scott Dunseth

CIK 0001356256 Name as filed on the most recent filing

Filed as Myers Scott Dunseth (12)

13 transaction lines · from 12 filings · filed 2006-05-26 to 2025-08-25 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

13 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-08-22 P, Open-market purchase Dynavax Technologies CorpDVAX 41,116, acquired Open Form 4 filing 0001029142-25-000120
2025-04-30 P, Open-market purchase Zentalis Pharmaceuticals, Inc.ZNTL 29,373, acquired Open Form 4 filing 0001725160-25-000094
2023-04-12 P, Open-market purchase Viridian Therapeutics, Inc.\DEVRDN 101,479, acquired Open Form 4 filing 0000950170-23-012595
2023-03-13 P, Open-market purchase Viridian Therapeutics, Inc.\DEVRDN 160,324, acquired Open Form 4 filing 0000950170-23-007570
2017-08-11 P, Open-market purchase Cascadian Therapeutics, Inc.CASC 20,543, acquired Open Form 4 filing 0001209191-17-048790
2017-05-12 P, Open-market purchase Cascadian Therapeutics, Inc.CASC 11,192, acquired Open Form 4 filing 0001209191-17-032832
2017-03-31 P, Open-market purchase Cascadian Therapeutics, Inc.CASC 8,229, acquired Open Form 4 filing 0001209191-17-025174
2017-03-20 P, Open-market purchase Cascadian Therapeutics, Inc.CASC 3,927, acquired Open Form 4 filing 0001209191-17-022141
2017-01-27 P, Open-market purchase Cascadian Therapeutics, Inc.CASC 77,039, acquired Open Form 4 filing 0001209191-17-006410
2016-08-17 P, Open-market purchase Cascadian Therapeutics, Inc.CASC 51,746, acquired Open Form 4 filing 0001209191-16-137799
2016-06-28 P, Open-market purchase Cascadian Therapeutics, Inc.CASC 50,000, acquired Open Form 4 filing 0001209191-16-129931
2006-05-25 P, Open-market purchase DOV Pharmaceutical IncDOVP 13,450, acquired Open Form 4 filing 0001005477-06-002816
2006-05-24 P, Open-market purchase DOV Pharmaceutical IncDOVP 13,450, acquired Open Form 4 filing 0001005477-06-002816

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 13
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Myers Scott Dunseth, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001356256

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.